Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
Public ClinicalTrials.gov record NCT01109121. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Parallel Group Study to Evaluate the Safety and Efficacy of Tranilast in Combination With Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase 2 study will be a multicenter, double-blind, randomized, active-comparator study to evaluate the safety and efficacy of tranilast in combination with allopurinol in patients with hyperuricemia and moderate to severe gout.
Study identification
- NCT ID
- NCT01109121
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 112 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2010 (Type not available)
- Primary completion
- Dec 2010 (Actual)
- Completion
- Jan 2011 (Actual)
- Last update posted
- Jan 6, 2011
2010 – 2011
United States locations
- U.S. sites
- 24
- U.S. states
- 20
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nuon Investigative Site | La Jolla | California | — | — |
| Nuon Investigative Site | Santa Maria | California | — | — |
| Nuon Investigative Site | Washington D.C. | District of Columbia | — | — |
| Nuon Investigative Site | New Port Richey | Florida | — | — |
| Nuon Investigative Site | Honolulu | Hawaii | — | — |
| Nuon Investigative Site | Boise | Idaho | — | — |
| Nuon Investigative Site | Bloomington | Indiana | — | — |
| Nuon Investigative Site | Owensboro | Kentucky | — | — |
| Nuon Investigative Site | Baltimore | Maryland | — | — |
| Nuon Investigative Site | Wheaton | Maryland | — | — |
| Nuon Investigative Site | Billings | Montana | — | — |
| Nuon Investigative Site | Omaha | Nebraska | — | — |
| Nuon Investigative Site | Reno | Nevada | — | — |
| Nuon Investigative Site | Teaneck | New Jersey | — | — |
| Nuon Investigative Site | Durham | North Carolina | — | — |
| Nuon Investigative Site | Cincinnati | Ohio | — | — |
| Nuon Investigative Site | Oklahoma City | Oklahoma | — | — |
| Nuon Investigative Site | Lake Oswego | Oregon | — | — |
| Nuon Investigative Site | Duncansville | Pennsylvania | — | — |
| Nuon Investigative Site | West Reading | Pennsylvania | — | — |
| Nuon Investigative Site | Charleston | South Carolina | — | — |
| Nuon Investigative Site | Greenville | South Carolina | — | — |
| Nuon Investigative Site | Waco | Texas | — | — |
| Nuon Investigative Site | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01109121, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 6, 2011 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01109121 live on ClinicalTrials.gov.